Avid Biosciences Shares Are Trading Higher After the Company Announced It Agreed to Be Acquired by GHO Capital Partners and Ampersand in a $1.1 Billion Transaction. Also, RBC Capital Raised Its Price Target on the Stock From $12 to $12.5.
Avid Biosciences Shares Are Trading Higher After the Company Announced It Agreed to Be Acquired by GHO Capital Partners and Ampersand in a $1.1 Billion Transaction. Also, RBC Capital Raised Its Price Target on the Stock From $12 to $12.5.
Avid Biosciences股價上漲，因公司宣佈同意被GHO Capital Partners和Ampersand以11億美元的交易收購。此外，RBC Capital將該股票的目標價格從12美元上調至12.5美元。
Avid Biosciences Shares Are Trading Higher After the Company Announced It Agreed to Be Acquired by GHO Capital Partners and Ampersand in a $1.1 Billion Transaction. Also, RBC Capital Raised Its Price Target on the Stock From $12 to $12.5.
Avid Biosciences股價上漲，因公司宣佈同意接受GHO Capital Partners和Ampersand以11億美元交易收購。此外，RBC Capital將股票的目標價從12美元上調至12.5美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間